AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dokomajilar, C.
Right arrow Articles by Dorsey, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dokomajilar, C.
Right arrow Articles by Dorsey, G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2006, p. 1893-1895, Vol. 50, No. 5
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.5.1893-1895.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Selection of Plasmodium falciparum pfmdr1 Alleles following Therapy with Artemether-Lumefantrine in an Area of Uganda where Malaria Is Highly Endemic

Christian Dokomajilar,1 Samuel L. Nsobya,2 Bryan Greenhouse,1 Philip J. Rosenthal,1 and Grant Dorsey1*

Department of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California,1 Department of Medicine, Makerere University, Kampala, Uganda2

Received 8 February 2006/ Returned for modification 1 March 2006/ Accepted 8 March 2006

Polymorphisms in the Plasmodium falciparum pfmdr1 gene were assayed in pretreatment samples and in samples from patients reinfected following therapy with artemether-lumefantrine. The pfmdr1 alleles 86N, 184F, and 1246D significantly increased in prevalence after treatment. All samples had a single pfmdr1 copy. Treatment with artemether-lumefantrine selects for polymorphisms that may alter antimalarial drug response.

* Corresponding author. Mailing address: University of California, San Francisco, Box 0811, San Francisco, CA 94143. Phone: (415) 206-4680. Fax: (415) 648-8425. E-mail: gdorsey{at}medsfgh.ucsf.edu.

Antimicrobial Agents and Chemotherapy, May 2006, p. 1893-1895, Vol. 50, No. 5
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.5.1893-1895.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.